Reply

Clin Gastroenterol Hepatol. 2019 Nov;17(12):2621-2622. doi: 10.1016/j.cgh.2019.05.015.

Authors

Yali Wu¹, Chengli Shen², Xinyue Chen¹

Affiliations

¹ International Medical Department, Beijing Youan Hospital, Capital Medical University, Beijing, China.
² Division of Surgical Oncology, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, Ohio.

PMID: 31653317
DOI: 10.1016/j.cgh.2019.05.015

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents*
Hepatitis B Surface Antigens
Humans
Interferons*

Substances

Antiviral Agents
Hepatitis B Surface Antigens
Interferons